Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Nature Communications|June 13, 2023
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinomaCharlie Saillard, Flore Delecourt, Benoit Schmauch, et al.European Journal of Cancer (Oxford, England : 1990)|November 3, 2021
Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)Leonor Benhaim, Olivier Bouché, Corinne Normand, et al.Science (New York, N.Y.)|April 13, 2013
Ribosomal protein SA haploinsufficiency in humans with isolated congenital aspleniaAlexandre Bolze, Nizar Mahlaoui, Minji Byun, et al.Blood Advances|May 2, 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular featuresRivers Fragneau, Sylvie Fraitag, Paul G Kemps, et al.Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.Nature Medicine|January 29, 2024
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinomaLingxi Jiang, Jiejie Qin, Yuting Dai, et al.Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.Plos One|February 25, 2021
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review networkGonzague de Pinieux, Marie Karanian, Francois Le Loarer, et al.Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.Nature Medicine|June 29, 2021
Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a childMasato Ogishi, Rui Yang, Caner Aytekin, et al.Pageof 5